8 ms·
Google Bets on Health
- jbob2000 11y agoI had a conversation with a coworker who used to build software for the criminal justice system. To make a long story short, it turned out to be impossible to make a good software system for the criminal justice system. Between the courts, police departments, and government, nobody was willing to give up any data, fearing they would lose their own value in the system. I fear that healthcare will suffer the same fate. Between insurance companies, doctors, hospitals, patients, governments, and every middleman inbetween, nobody is going to want a system that makes one of them irrelevant.
- harigov 11y agoI know Google is making large bets but I am not sure they can make so much of progress that doctors and insurance companies need to worry about their survival. If we ever reach that point, everyone in the population will face the heat.
- otoburb 11y agoDoctors and insurance frameworks that act as obstacles domestically may push Google to pursue healthcare developments in other countries with less onerous restrictions. In other words, I'm sure Google will find a path of least resistance to realize the benefits of their investments even if it means going outside of the US market.
- toomuchtodo 11y agoGoogle should partner with Watsi [1], who is already working on funding third world healthcare. [1] https://watsi.org/ https://watsi.org/
- seehafer 11y agoSome folks on the inside think Google has an ambition to replace the insurance companies. http://medcitynews.com/2016/01/google-biogen-payer-cms/ http://medcitynews.com/2016/01/google-biogen-payer-cms/
- specialist 11y agoBig Pharma will pay huge money for this data. Imagine targeted ads based on your medical history. This was exactly the scenario discussed, solving the "who'll pay?" problem, when our corporate overlords were negotiating data sharing with Google Health and Microsoft HealthVault. Fortunately, at the time, this exploitation of patient data wasn't permitted, so those efforts fizzled out. I've been out of the game for a few years, so I don't know the current legal and regulatory landscape.
- seehafer 11y ago> Between insurance companies, doctors, hospitals, patients, governments, and every middleman inbetween You can eliminate middlemen if you can show cost reductions for a player larger than the middleman. The big players are providers, payors and technology (pharma/device) companies. Plenty of middlemen in between those that can be made irrelevant.
- psaintla 11y agoYou would think that's the case but from experience it's not. I can name two hospitals in NYC that were supposed to see savings from EHR implementations but ended up having multiple competing EHRs that don't speak to each other because of conflicts of interest. You forget there in many cases there are many payors, tech vendors and providers within a single institution.
- wefarrell 11y agoThat's been my experience as well. EHR providers have no incentive to exchange data with each other and will do everything in their power not to. There are regional efforts towards interoperability but there needs to be more political will to mandate cooperation.
- dikaiosune 11y agoWhat about HL7? When I last worked with an EHR system (2? years ago), implementing HL7-based interop with other providers was all the rage so that they could eliminate fax machines when transferring patient records.
- psaintla 11y agoHL7 is a massive farce. It is an impossibly large standard that's difficult to understand and rarely used for interoperability.
- epmatsw 11y agoEh, Epic and Cerner interface fine, and offer HL7 interfaces, and Epic in particular bends over backwards to do what their customers want for implementations. My impression was that hospitals are (understandably) reluctant to allow their direct competitors direct access to information they've collected.
- Dwolb 11y agoThat's a good point and one that's starting to change a bit with the rise of integrated health systems (payor and provider integration). Intermountain Healthcare is one such organization.
- Milner08 11y agoYou forget that there is more than just the american market. Im sure that the NHS in the UK would love stuff like this.
- amscanne 11y agoI think the comment is pretty astute -- this is a big challenge. Even if Canada, where the state is effectively the sole insurer and determines treatments and pricing for everyone (arguably more centralized than in the UK), the actors in the healthcare system are still wary of connecting to each other. I learned about this recently from someone I know who is working in "health informatics" at a hospital. Their systems don't share any data with other hospitals, the ministry (the insurer and regulator), etc. There's an initiative to have hospitals in just a single major urban area connected, and despite it being a few years in only a few hospitals are actually participating.
- tyingq 11y ago>>nobody was willing to give up any data, fearing they would lose their own value in the system I suspect this is correct, particularly between the insurance companies and the providers. The coding of what exactly was done directly drives the reimbursement that the providers get. Thus, there's a clear incentive to be opaque and show the insurers only what you need to. Sometimes for good reason (insurers denying coverage solely for cost reasons), sometimes not (billing fraud).
- petra 11y agoThey can always play the political game , like UBER - maybe building a solution and advertising it straight to patients and/or politicians(and legally bribe them if needs be). Once patients groups and politicians will be in the mix , it will be much harder for the healthcare system to resist change.
- agumonkey 11y agoIt's an interesting status, kinda like game theory meeting system theory. Communication but only to a certain degree otherwise the organs die.
- tdaltonc 11y agoIs google big enough to set up an independent "healthcare stack" to just do their own thing?
- ThomPete 11y agoHealthcare has one advantage and that is that the data ultimately is owned by the patients. So this might actually allow them to get access to the data.
- petra 11y agoMaybe it's theoretically owned by the patient , but is there any place in the world, that if a patient wants the data , in a common electronic format , he gets it ? Heck, even the stuff you do get is written intentionally in bad handwriting by doctors(which they do so to protect themselves, and probably at a risk of harming patients).
- specialist 11y agoBack when healthcare information exchanges were a new thing, one of the competing notions was for patients to "carry" around their own medical records, explicitly granting access on a need-to-know basis. Thumb drive, cloud storage, whatever. I know that your statement isn't suggesting this strategy. I only mention it to note the logical conclusion of a patient-centric system. Currently, getting access to your own medical records is like getting your own financial records and credit reports, only worse. Even though I am my data, it is my identity, my self, none of the aggregators and purveyors, who profit from my data, see it that way, and only comply reluctantly.
- specialist 11y agoYup. Only way for the US to have portable medical records is to switch to single payer. Source: I designed, implemented, supported five healthcare information exchanges.
- reasonattlm 11y agoThe first rejuvenation biotechnology companies developing therapies to target the aging process itself - rather than producing compensatory/palliative treatments for specific manifestations of late stage aging - are already past their seed stage. Unity Biotechnology and Oisin Biotechnology are both working on different methods of senescent cell clearance, for example. Removal of senescent cells has been demonstrated to extend life in mice, improve cardiovascular health, etc. It makes sense to back all plausible ventures in this area of development, and since there are at least seven classes of cell and tissue damage that cause aging, there will be a fair number of such ventures in the years ahead. Next up is probably glucosepane cross-link clearance or mitochondrial DNA repair, or perhaps transthyretin amyloid clearance if it ever gets liberated from the disinterested patronage of GSK. Since Google has a clear interest in this area, even if they are going about it by supporting exactly the wrong lines of R&D at the moment, I imagine they will be involved in the growth of these companies and technologies as they continue to prove themselves effective in animal studies. The target market is every human being over the age of 30, with a course of treatment every few years to a decade. The treatment will be some form of mass-produced infusion, such as a gene therapy. Comparable technologies from a production standpoint, such as biologics for autoimmune conditions, run at $1-10K per treatment even in the wildly dysfunction US medical system. You can run the numbers; from an economic perspective longevity assurance treatments that work will make most historical therapies look like small potatoes.
- sounds 11y agoCan you explain your analysis, "going about it by supporting exactly the wrong lines"?
- eropple 11y agoGive that another read. Even if Google is supporting the wrong lines of R&D, money is going into the problem, and that's attractive to further development.
- reasonattlm 11y agoThere is an audio interview with Aubrey de Grey (SENS Research Foundation) and Brian Kennedy (Buck Institute for Aging Research) in which that is discussed in some detail. http://mendelspod.com/podcasts/brian-kennedy-and-aubrey-de-grey-their-converging-approaches-aging-research/ http://mendelspod.com/podcasts/brian-kennedy-and-aubrey-de-g... See the "response to Calico and HLI" portion. With reference to Calico, the relevant part is this: "I would say that definitely their hearts are in the right place, but they are a regular, perfectly normal company. They want to make profits fairly soon. Calico have set themselves up as a completely unusual company with the goal of doing something very long-term, however long it takes, they want to actually fix aging. They said so - Larry Page was perfectly clear about that. The question is how are they going about it, and that's getting really interesting. The first thing that they've done, which I feel is an absolutely spectacularly good move, is to bifurcate their work into a relatively short-term track and a long-term track. The short term track involves drug discovery for age-related diseases, doing deals with big companies like Abbvie, and so on. That's all very wonderful and all very lucrative in the relatively short term, and has more or less nothing to do with the mission for which Calico was set up - but it is a fabulous way to insulate the stuff that they do that is to do with why Calico was set up from shareholder pressure. It gets a little more complicated though. So then on the long term side, the stuff being led by David Botstein and Cynthia Kenyon, the question is how are they going about their mission. Of course an awful lot of this unknown because they are a secretive company, but from the perspective of whom they are hiring, and what kinds of work those people have done in the past, one can certainly say that they are not just focusing on one approach. They are interested in diversity. My only real concern is that they may be emphasizing a curiosity-driven long term exploratory approach to an unnecessary degree. I'm all for finding out more and more about aging, but I'm also all for using what we've already found out to the best of our ability to try stuff and see what we can do. I should emphasize that this is only my impression from a very limited amount of information available, but my impression is that it is perhaps turning into an excessively curiosity-driven, excessively basic science, inadequately translational outfit. And that's kind of what I feared when Botstein came along in the first place, because he's on record as saying he doesn't have a translational bone in his body." The basic point is that they appear to be aiming at drug development to slow aging, which is very hard and speculative. The basic goal is to create a new global metabolic state that ages more slowly than the natural one. The calorie restricted state is an obvious one to try emulating, but that is also very hard: understanding sufficient to do this requires a complete map of cellular biology. More than a decade of research into sirtuins, and a billion dollars in investment, went nowhere for example. That was classed as a promising direction at the outset, and much hyped. But what if you did create a new metabolic state? The outcome would be a small increase in life span, a small slowing in aging, and a therapy that would be useless for old people because they are already damaged. Compare that with the SENS repair approaches, such as removal of senescent cells, which is already producing far more robust results in mice, and at a fraction of the cost. Such therapies can be used over and again, and produce new benefits each time to the degree that they clear out damage. They are also useful and beneficial for old people, as they will reduce their damage load. So in short, we can do the slow, expensive, useless path, or the fast, cheap, effective path. So far the research community has chosen the former. Why they have done this is a long, long cultural discussion on incentives and regulation and the nature of how research into age-related diseases has typically worked over the last century. What will change this is a continuing set of convincing animal data from SENS programs.
- matt_wulfeck 11y agoI can't help but feel the motivating factor here is not helping people live longer (invest in food storage, transportation, and production and help millions of people survive). Instead this seems to me more like wealthy folks beginning to fear the realization that someday they will grow old and die like the rest of us.
- haberman 11y agoImagine being in a situation where doing anything that benefits both yourself and others is used as evidence of your selfishness because it will benefit you. When did win/win become a bad thing? Would you rather these rich people were building bigger mansions instead?
- asdfologist 11y agoYeah but your way of thinking isn't good for getting karma on HN. Pretty much any HN thread on a big company doing something good is dominated by cynics who cannot fathom the possibility of people out there wanting to make money and benefit the world at the same time.
- reasonattlm 11y agoSpeaking as an advocate for the cause, I can assure you that isn't it. Wealth doesn't grant vision. Most wealthy people have exactly the same biases and preconceptions about aging as everyone else. If it was otherwise, it wouldn't be at all hard to raise funds for initiatives like the SENS Research Foundation's program aimed at medical control of aging. As it is, the number of the ultra-wealthy who have supported this cause is well below 1%, and those have been fairly cautious investments in the grand scheme of things, e.g. those by Peter Thiel. What is happening at the moment is an initial tipping point of sorts across the entire population in the realization that, hey, treating aging as a medical condition is plausible. Researchers have been saying this for a decade, with increasing volume following the pro-longevity faction winning the cultural battles within the scientific community, but it takes time to bootstrap a movement and get to the point at which Prudential puts up posters suggesting that people should think about living to 150. We may not even be at the main 10% support tipping point yet in the broader population. A recent Pew study suggests that the majority of people continue to believe that the current state of things is the best state of things, and they don't want live longer because people don't live longer. People want to be slightly better than their peers. Live to 90, because that's a little more than what other people have on average. Be more healthy as you decay into death, because that's a little more than other people have. Stasis is the default opinion, which has always struck me as crazed given the tangible, obvious pace of progress in technology that we are living through. http://www.pewforum.org/2013/08/06/living-to-120-and-beyond-americans-views-on-aging-medical-advances-and-radical-life-extension/ http://www.pewforum.org/2013/08/06/living-to-120-and-beyond-... In the end this is no different than any other field of human endeavor. It takes unreasonable visionaries to force beneficial progress down everyone else's throats, and once done everyone else agrees that it was self-evident and obvious.
- melted 11y agoGoogle did bet on healthcare once before. I don't know if you remember, but they noped out of that after about 2 years, and Microsoft noped out shortly thereafter IIRC. Once you nope out of something so suddenly, it becomes difficult to convince the market that you're serious about it this time.
- nostromo 11y agoGoogle Health was a fairly simple CRUD app. Trying to cure cancer or Alzheimer's disease is in a different universe entirely.
- melted 11y agoTrying to cure cancer or Alzheimer's requires actual medical research, which is a money sink at the scale Google is ill prepared to tolerate. So it'll be some kind of data management one way or another.
- cowsandmilk 11y agoGoogle Ventures is just a VC fund. And they are funding businesses that are largely agreed to be legit enterprises. The two examples in the article: Foundation Medicine: sequences tumor cells to use for directing cancer treatment. There have been some high profile cases from academic research centers where this has saved lives. Roche purchased over 50% of the company last year. Editas: Everyone in biology has heard of CRISPR. The company was founded by Zhang and Doudna, although it is now primarily a Broad company (meaning Zhang). It is led by Bosley who previously led Avila to being acquired by Celgene. The notion that these investments are not doing "actual medical research" is ridiculous.
- melted 11y agoSince when "Google Ventures makes a minority investment" means "Google makes a bet"?
- agumonkey 11y ago
- grondilu 11y agoIMHO that's sad, really. If they focus on things like that, it either means that they feel they don't have much more to bring in their original activity (A.I., networks and computer science), or that they have lost interest in these subjects and want to focus more on "saving lives". Kind of like Bill Gates and his philanthropic activity post-Microsoft. Philanthropy is nice and all, but that's not why I'm interested in tech companies.
- placeybordeaux 11y agoOr they see a better ROI. The entire world's population is aging and death by accident is becoming more and more rare. Health care can essentially become an inelastic good, if you can decrease the entry price you will pick up more and more customers. If you do it right you can get customers for life and then use your product to extend their life. Not to mention the rich people that fund this can rationalize away the existential problem.
- grondilu 11y agoBut big pharma companies have existed before Google. I was not interested in them and I don't want Google/Alphabet turn into one of them. If they focus on healthcare, they're doing something completely different which is of no interest to me. As a shareholder of Alphabet, I feel this is some kind of a treason.
- maxerickson 11y agoYou are aware of the share structure of Alphabet? It was designed at the outset (the IPO of Google) to reduce the power of ordinary shareholders. http://www.fool.com/investing/general/2015/10/29/is-a-vote-at-alphabet-inc-worth-15.aspx http://www.fool.com/investing/general/2015/10/29/is-a-vote-a... or http://blogs.wsj.com/cfo/2015/08/12/googles-multi-class-stock-structure-made-alphabet-move-unique/ http://blogs.wsj.com/cfo/2015/08/12/googles-multi-class-stoc...
- grondilu 11y ago
- ed_blackburn 11y agoForgive my ignorance but with the UK government being very bullish with enforcing its (in some places google influenced) ideology upon the NHS. My interest in such matters has suddenly piqued. What are these Health Care software systems? Are they distributed CRUD systems between different locations and actors? Are they event driven systems that push a leaner, more efficient process through the health care system? Are they big data / AI products for the macro that identify patterns to help policy, planning, budgets or micro to help as early warning for identify suspicious patterns in areas, surgeries or even an individuals monitoring? I can see software being incredibly helpful, I can also see it being thoroughly expensive and intensive if the NHS has to go through a multi-million-pound multi-year tending process that is almost immediately invalidated by factors such as it'll need customising so heavily it'll take years to actually tailor correctly, all medical records will need migrating making the entire system redundant before it starts, it has to work across all trusts at once, all patients have to consent etc. I want to see this help. Software can really benefit everyone, but I fear we are heading for a horrific car crash of 'enterprise' Health Care IT sucking money out of wards and doctors away from patients. Someone convince me otherwise :)
- mtgx 11y agoI'm looking forward to seeing Google put its DeepMind AI and quantum computer to work on health problems and various cures in the next 5-15 years.
- sirkneeland 11y agoWhen describing his vision for GV and the health-care areas he wants to invest in, Maris lists genomics, cancer, central nervous system disorders and aging At the risk of sounding wildly selfish, I hope "central nervous system disorders" includes tinnitus. It's hell.
- abawany 11y agoI suffer from this too and tried the very gimmicky but free/easy trick described at https://np.reddit.com/r/WTF/comments/3l3uri/these_guys_lighting_a_mortar_shell_in_their_garage/cv3474n https://np.reddit.com/r/WTF/comments/3l3uri/these_guys_light... . It gives me relief for a few minutes. When one has spent as long as one can remember with this noise, even perfect silence for a few minutes is rather heavenly.
- danieltillett 11y agoI don’t have tinnitus, but I love to learn of hacks like this.
- matt_wulfeck 11y agoDeath is a gift. We are not built to live forever and we should never wish it so. I encourage us all to focus on increasing the quality of all of our lives and not the quantity of our days. "The hate of men will pass, and dictators die, and the power they took from the people will return to the people; and so long as men die, liberty will never perish." - Charlie Chapman "The Dictator"
- andylei 11y agohttp://www.nickbostrom.com/fable/dragon.html http://www.nickbostrom.com/fable/dragon.html
- rdl 11y agoI've never understood people who believe this, but am happy to let them die if they wish.
- sangnoir 11y ago> I've never understood people who believe this You can think of your death as a hard-and-fast deadline to achieve all your dreams - this is pretty motivating for some people. Steve jobs had this to say in a 2005 commencement speech[1]: "Remembering that I'll be dead soon is the most important tool I've ever encountered to help me make the big choices in life. Because almost everything — all external expectations, all pride, all fear of embarrassment or failure — these things just fall away in the face of death, leaving only what is truly important". Other people's death's can be a gift as well: tyrants don't get to rule forever, and out-dated ideas die with their generations. Immortality would be a good thing in a "Culture"-like society: i.e. if we manage to solve all the other human problems (like greed and poverty) first 1. http://news.stanford.edu/news/2005/june15/jobs-061505.html http://news.stanford.edu/news/2005/june15/jobs-061505.html
- dragonwriter 11y ago> You can think of your death as a hard-and-fast deadline to achieve all your dreams For it to be useful as a hard-and-fast deadline, you have to know in advance exactly when it will come. Otherwise, its just knowledge that there will be a deadline at some point in the future, which is very different than a hard-and-fast deadline.
- mhkool 11y agoThe article has too many words like "bets" and "investments". There is no strategy, other than do something not regulated by the FDA. This is definitely too weak. A free and great advice: look at Dr Mark Hyman and Dr Dale Bredesen. Study what they do, how they do it and draw your conclusions. I guarantee you, you will be amazed about your own conclusions!